This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...